Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertension
- 1 June 1998
- journal article
- Published by Elsevier in Kidney International
- Vol. 53 (6), 1479-1482
- https://doi.org/10.1046/j.1523-1755.1998.00924.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.JCI Insight, 1997
- The Angiotensinogen T235 Variant and the Use of Antihypertensive Drugs in a Population-Based CohortHypertension, 1997
- Enhanced Pressor Response to Angiotensin I in Normotensive Men With the Deletion Genotype (DD) for Angiotensin-Converting EnzymeHypertension, 1995
- The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children.JCI Insight, 1995
- Angiotensin-converting enzyme polymorphism and essential hypertensionThe Lancet, 1994
- Rapid detection of the hypertension-associated Met235→ Thr allele of the human angiotensinogen geneHuman Molecular Genetics, 1993
- The angiotensin I converting enzyme gene and predisposition to high blood pressure.Hypertension, 1993
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertensionBiochemical and Biophysical Research Communications, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990